- April 05, 2016 Spero Therapeutics Hires Cristina Larkin as Chief Commercial Officer
- March 02, 2016 Spero Therapeutics Hires Cristina Larkin as Chief Commercial Officer
- February 29, 2016 Spero Therapeutics to Present at Cowen and Company 36th Annual Health Care Conference
- February 02, 2016 Spero Therapeutics Announces $30 Million Series B Preferred Financing
- January 19, 2016 Spero Therapeutics Hires Former Biomedical Advanced Research and Development Authority (BARDA) Anti-Infectives Program Chief
- January 07, 2016 Spero Therapeutics Licenses Dihydrofolate Reductase Inhibitors from Promiliad Biopharma to Enhance Anti-Infective Pipeline
- September 17, 2015 Spero Expands Leadership Team, Advisory Board with Industry Veterans
- July 21, 2015 Spero Achieves First Milestone Payment in Anti-Infective Partnership with Roche
- June 08, 2015 Spero Completes $30 Million Financing
- August 21, 2014 Spero Therapeutics Announces Publication in PLoS Pathogens Describing Potential Strategy for Combating Resistant Gram-Negative Bacteria
Displaying 71 - 80 of 83 results